Why MSK?

Why We Give Back to Memorial Sloan Kettering Cancer Center

At Granny-O-La®, we believe that doing well and doing good should go hand in hand. 

That is why 50% of Granny-O-La® profits are donated to Memorial Sloan Kettering Cancer Center (MSK), one of the world's leading institutions dedicated entirely to cancer. 

But why MSK? 

MSK is a world leader in cancer research and care. 

Founded in 1884, MSK has spent more than 140 years advancing the prevention, diagnosis and treatment of cancer. 

In 1971, MSK became one of the first institutions in the country to receive the National Cancer Institute's Comprehensive Cancer Center designation, reserved for institutions meeting rigorous standards in multidisciplinary cancer research. 

Today, MSK continues to set the standard. 

In 2026, Newsweek ranked MSK the #1 hospital in the world for oncology. And for more than 35 consecutive years, MSK has been ranked among the top two cancer hospitals in the United States by U.S. News & World Report. 

Where Research Becomes Hope 

What makes MSK extraordinary is the collaboration between its scientists and physicians. 

MSK has more than 120 research laboratories dedicated to understanding cancer and one of the world's largest clinical research programs, with nearly 2,000 clinical trials underway at any given time. 

In 2025 alone: 

10 new cancer drugs were approved by the FDA based on clinical trials in which MSK played a pivotal role

• MSK researchers published more than 2,500 scientific papers 

Over the years, MSK researchers have also helped pioneer transformative treatment approaches, including immunotherapy, CAR T cell therapy, and cancer vaccines. 

Why Your Purchase Matters 

When you buy Granny-O-La®, you're not simply buying a bag of granola. 

You're helping us support an institution where today's discoveries can become tomorrow's treatments. 

Your purchase helps Granny-O-La® give back to a place where brilliant scientists, physicians, nurses and caregivers are working every day toward one extraordinary mission: 

Ending cancer for life. 

That is why we are proud to donate 50% of our profits to Memorial Sloan Kettering Cancer Center. 

And that is why we say Granny-O-La® was born to give back. 

Simply the Best Granola. With a purpose.

MSK Facts:

• Founded in 1884, MSK is one of the oldest institutions in the United States devoted exclusively to cancer.

• NCI Comprehensive Cancer Center since 1971. MSK was among the first institutions to receive this designation, which recognizes centers meeting rigorous standards for multidisciplinary cancer research.

• #1 cancer hospital in the world. In Newsweek's 2026 World's Best Specialized Hospitals ranking, MSK was ranked No. 1 in the world for oncology.

• Top 2 cancer hospital in the United States for more than 35 consecutive years according to U.S. News & World Report. MSK was ranked No. 2 nationally for cancer care in its most recent ranking.

• More than 120 research laboratories are dedicated to understanding cancer, and MSK has more than 38 specialized core research facilities.

• More than 2,500 scientific papers published in 2025, advancing knowledge of cancer and human biology.

• 10 FDA approvals in 2025 were based on clinical trials in which MSK played a pivotal role.

• MSK researchers helped pioneer checkpoint inhibitor immunotherapy and CAR T-cell therapy, two approaches that have fundamentally changed cancer treatment.

• MSK's research has contributed to 11 FDA-approved drugs developed in its laboratories, according to MSK's historical milestones.

• MSK has more than 900 clinical trials studying cancer prevention, diagnosis and treatment.

• Its physicians and scientists include 27 members of the National Academy of Medicine, 14 members of the National Academy of Sciences and 8 Howard Hughes Medical Institute investigators.

• In 2025, MSK received Magnet® designation for nursing excellence for the third time, one of the highest distinctions in nursing.

• In 2026, MSK was ranked 12th among the world's top 70 research institutions in Clarivate's analysis of research powerhouses.

And perhaps most importantly funds from Granny-O-La are helping fund original research, clinical trials, education and discoveries that can change the future of cancer care.